Respiri Limited (RSHUF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 456.91 Thousand AUD | -92.81% |
| 2023 | 6.35 Million AUD | -10.05% |
| 2022 | 7.06 Million AUD | -36.72% |
| 2021 | 11.16 Million AUD | 18.03% |
| 2020 | 9.46 Million AUD | 11.57% |
| 2019 | 8.48 Million AUD | 107.43% |
| 2018 | 4.08 Million AUD | 21.61% |
| 2017 | 3.36 Million AUD | -2.15% |
| 2016 | 3.43 Million AUD | -38.54% |
| 2015 | 5.59 Million AUD | -50.27% |
| 2014 | 11.24 Million AUD | 92.83% |
| 2013 | 5.82 Million AUD | 1.95% |
| 2012 | 5.71 Million AUD | -17.08% |
| 2011 | 6.89 Million AUD | 11.18% |
| 2010 | 6.2 Million AUD | -9.22% |
| 2009 | 6.83 Million AUD | -37.76% |
| 2008 | 10.97 Million AUD | 101.34% |
| 2007 | 5.45 Million AUD | 630.15% |
| 2006 | 746.83 Thousand AUD | 0.63% |
| 2005 | 742.18 Thousand AUD | -11.0% |
| 2004 | 833.9 Thousand AUD | -78.63% |
| 2003 | 3.9 Million AUD | -53.53% |
| 2002 | 8.39 Million AUD | 3458.9% |
| 2001 | 236 Thousand AUD | 104.04% |
| 2000 | -5.84 Million AUD | -225.41% |
| 1999 | -1.79 Million AUD | -151.51% |
| 1998 | -714.42 Thousand AUD | -148.14% |
| 1997 | 1.48 Million AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.75 Million AUD | -9.09% |
| 2024 FY | 7.49 Million AUD | 17.95% |
| 2024 Q4 | 4.27 Million AUD | 143.52% |
| 2023 FY | 6.35 Million AUD | -10.05% |
| 2023 Q2 | 1.97 Million AUD | -26.41% |
| 2023 Q4 | 1.93 Million AUD | -2.21% |
| 2022 FY | 7.06 Million AUD | -36.72% |
| 2022 Q2 | 2.74 Million AUD | -23.87% |
| 2022 Q4 | 2.68 Million AUD | -2.29% |
| 2021 Q2 | 6.34 Million AUD | 7.8% |
| 2021 Q4 | 3.6 Million AUD | -43.11% |
| 2021 FY | 11.16 Million AUD | 18.03% |
| 2020 FY | 9.46 Million AUD | 11.57% |
| 2020 Q2 | 3.57 Million AUD | -17.73% |
| 2020 Q4 | 5.88 Million AUD | 64.48% |
| 2019 Q4 | 4.34 Million AUD | 5.22% |
| 2019 Q2 | 4.13 Million AUD | 70.34% |
| 2019 FY | 8.48 Million AUD | 107.43% |
| 2018 Q2 | 1.65 Million AUD | 11.35% |
| 2018 FY | 4.08 Million AUD | 21.61% |
| 2018 Q4 | 2.42 Million AUD | 46.2% |
| 2017 Q4 | 1.48 Million AUD | -20.42% |
| 2017 FY | 3.36 Million AUD | -2.15% |
| 2017 Q2 | 1.87 Million AUD | 13.38% |
| 2016 Q2 | 1.67 Million AUD | -33.47% |
| 2016 Q4 | 1.65 Million AUD | -1.7% |
| 2016 FY | 3.43 Million AUD | -38.54% |
| 2015 Q4 | 2.52 Million AUD | -17.67% |
| 2015 FY | 5.59 Million AUD | -50.27% |
| 2015 Q2 | 3.06 Million AUD | -6.47% |
| 2014 Q2 | 7.3 Million AUD | 145.29% |
| 2014 Q4 | 3.27 Million AUD | -55.1% |
| 2014 FY | 11.24 Million AUD | 92.83% |
| 2013 FY | 5.82 Million AUD | 1.95% |
| 2013 Q4 | 2.97 Million AUD | 4.32% |
| 2013 Q2 | 2.85 Million AUD | 0.0% |
| 2012 FY | 5.71 Million AUD | -17.08% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 FY | 6.89 Million AUD | 11.18% |
| 2010 FY | 6.2 Million AUD | -9.22% |
| 2010 Q4 | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 FY | 6.83 Million AUD | -37.76% |
| 2008 FY | 10.97 Million AUD | 101.34% |
| 2008 Q4 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | 5.45 Million AUD | 630.15% |
| 2006 Q4 | - AUD | 0.0% |
| 2006 FY | 746.83 Thousand AUD | 0.63% |
| 2005 FY | 742.18 Thousand AUD | -11.0% |
| 2005 Q4 | - AUD | 0.0% |
| 2004 FY | 833.9 Thousand AUD | -78.63% |
| 2004 Q4 | - AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2003 FY | 3.9 Million AUD | -53.53% |
| 2002 Q4 | - AUD | 0.0% |
| 2002 FY | 8.39 Million AUD | 3458.9% |
| 2001 Q4 | - AUD | 0.0% |
| 2001 FY | 236 Thousand AUD | 104.04% |
| 2000 FY | -5.84 Million AUD | -225.41% |
| 1999 FY | -1.79 Million AUD | -151.51% |
| 1998 FY | -714.42 Thousand AUD | -148.14% |
| 1997 FY | 1.48 Million AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | 703 Thousand USD | 35.005% |
| SS Innovations International, Inc. | 21.38 Million USD | 97.863% |
| Össur hf. | 396.18 Million USD | 99.885% |
| Össur hf. | 396.18 Million USD | 99.885% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| QHSLab, Inc. | 961.65 Thousand USD | 52.487% |
| BrainsWay Ltd. | 28.01 Million USD | 98.369% |
| BioElectronics Corporation | 740.67 Thousand USD | 38.311% |
| AVITA Medical, Inc. | 80.77 Million USD | 99.434% |
| Zecotek Photonics Inc. | 3.46 Million USD | 86.8% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| Wellstar International, Inc. | 1.79 Million USD | 74.541% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 98.639% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 97.902% |
| Escalon Medical Corp. | 5.25 Million USD | 91.298% |
| Aurora Spine Corporation | 8.65 Million USD | 94.722% |
| NewCardio, Inc. | 9.56 Million USD | 95.223% |
| Avitar, Inc. | 3.56 Million USD | 87.2% |
| Vivos Inc. | 2.78 Million USD | 83.606% |
| Theraclion SA | 7.43 Million USD | 93.859% |
| Kelyniam Global, Inc. | 2.27 Million USD | 79.918% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| REMSleep Holdings, Inc. | 1.01 Million USD | 54.98% |
| Positron Corporation | 1 Million USD | 54.639% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -4.917% |
| Nanomix Corporation | 8.36 Million USD | 94.54% |
| Wellness Center USA, Inc. | 1.29 Million USD | 64.706% |
| Stratec SE | 46.32 Million USD | 99.014% |
| Heart Tronics, Inc. | 14.46 Million USD | 96.84% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -279.1% |
| Electromedical Technologies, Inc. | 3.11 Million USD | 85.31% |
| Lombard Medical, Inc. | 30.29 Million USD | 98.492% |
| ALR Technologies Inc. | 6.33 Million USD | 92.789% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.956% |
| Vycor Medical, Inc. | 1.27 Million USD | 64.177% |
| VMS Rehab Systems, Inc. | 63.63 USD | -717979.522% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -121.353% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 86.919% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 96.771% |
| Ingen Technologies, Inc. | 1.88 Million USD | 75.725% |
| United American Healthcare Corporation | 59 Thousand USD | -674.431% |
| Odyssey Group International, Inc. | -14.26 Million USD | 103.204% |
| IR-Med Inc. | 4.89 Million USD | 90.664% |
| Polarean Imaging plc | 12.24 Million USD | 96.268% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -12.13% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | 28.01% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | 73.052% |
| Medical Supply International USA, Inc. | 1.32 Million USD | 65.398% |
| Urologix, Inc. | 10.09 Million USD | 95.473% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | 63.833% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 92.319% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -98.45% |
| Smith & Nephew plc | 3.46 Billion USD | 99.987% |
| NIOX Group Plc | 22.27 Million USD | 97.949% |
| Fuse Medical, Inc. | 10.35 Million USD | 95.585% |
| Broncus Holding Corporation | 38.15 Million USD | 98.802% |
| Brain Scientific Inc. | 9.66 Million USD | 95.271% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 95.565% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -652.766% |